Forsteo

Forsteo (Teriparatide) is a subcutaneous medication used to treat osteoporosis. It helps improve bone density and reduce fracture risk. Learn more about this EU-manufactured treatment.

Forsteo, containing the active ingredient Teriparatide, is primarily used for the treatment of osteoporosis in individuals at high risk of fractures. This medication works by stimulating bone formation, helping to strengthen bones and reduce the likelihood of breaks. It is often prescribed for those who have not responded well to other osteoporosis treatments. Forsteo is administered via subcutaneous injection, making it a convenient option for those who need consistent therapy.

Common effects of Forsteo may include mild to moderate reactions at the injection site, such as redness, swelling, or itching. Some users may also experience dizziness, headache, or nausea. These effects are generally temporary and should subside as the body adjusts to the medication. If any severe or persistent side effects occur, it is important to consult a healthcare provider.

Forsteo should be used with caution in individuals with a history of bone cancer or metabolic bone diseases. It is important to follow the prescribed dosage and administration instructions carefully. Patients should also inform their healthcare provider about any other medications they are taking to avoid potential interactions. Always store Forsteo properly to maintain its effectiveness.

Forsteo may interact with certain medications, including those that affect bone metabolism or calcium levels. It is important to discuss all current medications with a healthcare provider before starting Forsteo. Additionally, alcohol consumption should be moderated, as it may affect the body's response to the medication. Always consult a healthcare professional for personalized advice.